

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | monoubiquitinated protein deubiquitination (GO:0035520) | 5.73206314 |
| 2 | mitotic metaphase plate congression (GO:0007080) | 5.50087128 |
| 3 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.28725342 |
| 4 | regulation of establishment of cell polarity (GO:2000114) | 5.27667105 |
| 5 | nuclear pore complex assembly (GO:0051292) | 5.26130026 |
| 6 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 5.07429997 |
| 7 | mitotic chromosome condensation (GO:0007076) | 5.01493395 |
| 8 | regulation of RNA export from nucleus (GO:0046831) | 4.89177489 |
| 9 | meiotic chromosome segregation (GO:0045132) | 4.85947111 |
| 10 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.83965035 |
| 11 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 4.68916798 |
| 12 | protein localization to kinetochore (GO:0034501) | 4.67855035 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.63337262 |
| 14 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 4.54970519 |
| 15 | nuclear pore organization (GO:0006999) | 4.51820649 |
| 16 | histone lysine demethylation (GO:0070076) | 4.48318144 |
| 17 | histone demethylation (GO:0016577) | 4.46643458 |
| 18 | protein localization to chromosome, centromeric region (GO:0071459) | 4.45720822 |
| 19 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.35790308 |
| 20 | metaphase plate congression (GO:0051310) | 4.35762041 |
| 21 | regulation of spindle organization (GO:0090224) | 4.29896289 |
| 22 | histone H3-K36 demethylation (GO:0070544) | 4.26915034 |
| 23 | DNA replication checkpoint (GO:0000076) | 4.25191828 |
| 24 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.24643122 |
| 25 | mitotic sister chromatid cohesion (GO:0007064) | 4.23452377 |
| 26 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 4.19267775 |
| 27 | sphingosine metabolic process (GO:0006670) | 4.15020282 |
| 28 | sister chromatid cohesion (GO:0007062) | 4.13809476 |
| 29 | protein K6-linked ubiquitination (GO:0085020) | 4.12100080 |
| 30 | pore complex assembly (GO:0046931) | 4.06872737 |
| 31 | protein dealkylation (GO:0008214) | 4.04773888 |
| 32 | protein demethylation (GO:0006482) | 4.04773888 |
| 33 | inner cell mass cell proliferation (GO:0001833) | 4.01216999 |
| 34 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 3.96196179 |
| 35 | snRNA transcription (GO:0009301) | 3.95034396 |
| 36 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.91520434 |
| 37 | diol metabolic process (GO:0034311) | 3.91166223 |
| 38 | response to UV-C (GO:0010225) | 3.90779743 |
| 39 | microtubule depolymerization (GO:0007019) | 3.84402720 |
| 40 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.82792557 |
| 41 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.77364904 |
| 42 | establishment of chromosome localization (GO:0051303) | 3.73431632 |
| 43 | mitotic sister chromatid segregation (GO:0000070) | 3.71278044 |
| 44 | regulation of meiosis I (GO:0060631) | 3.58869134 |
| 45 | protein localization to chromosome (GO:0034502) | 3.57161773 |
| 46 | histone H2A monoubiquitination (GO:0035518) | 3.57120137 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.55304133 |
| 48 | positive regulation of granulocyte differentiation (GO:0030854) | 3.52012140 |
| 49 | histone H3-K9 demethylation (GO:0033169) | 3.51350907 |
| 50 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.51215652 |
| 51 | positive regulation of chromosome segregation (GO:0051984) | 3.50995715 |
| 52 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.47167352 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.44874691 |
| 54 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.42563495 |
| 55 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.42563495 |
| 56 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.42563495 |
| 57 | negative regulation of cell aging (GO:0090344) | 3.41033026 |
| 58 | mitotic nuclear envelope disassembly (GO:0007077) | 3.40707133 |
| 59 | oocyte maturation (GO:0001556) | 3.38360568 |
| 60 | regulation of mitotic spindle organization (GO:0060236) | 3.36513908 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33560308 |
| 62 | DNA synthesis involved in DNA repair (GO:0000731) | 3.31838021 |
| 63 | DNA unwinding involved in DNA replication (GO:0006268) | 3.28822085 |
| 64 | cellular response to gamma radiation (GO:0071480) | 3.28339677 |
| 65 | regulation of sister chromatid cohesion (GO:0007063) | 3.28108430 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27530527 |
| 67 | sister chromatid segregation (GO:0000819) | 3.26373956 |
| 68 | sphingoid metabolic process (GO:0046519) | 3.23751837 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22855940 |
| 70 | kinetochore assembly (GO:0051382) | 3.22852219 |
| 71 | negative thymic T cell selection (GO:0045060) | 3.22185163 |
| 72 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21595794 |
| 73 | kinetochore organization (GO:0051383) | 3.19249196 |
| 74 | meiosis I (GO:0007127) | 3.18469516 |
| 75 | chromosome segregation (GO:0007059) | 3.18333948 |
| 76 | negative T cell selection (GO:0043383) | 3.17925192 |
| 77 | male meiosis I (GO:0007141) | 3.11979719 |
| 78 | corticosteroid receptor signaling pathway (GO:0031958) | 3.09649298 |
| 79 | regulation of keratinocyte proliferation (GO:0010837) | 3.09590897 |
| 80 | membrane disassembly (GO:0030397) | 3.09561887 |
| 81 | nuclear envelope disassembly (GO:0051081) | 3.09561887 |
| 82 | DNA replication-independent nucleosome organization (GO:0034724) | 3.08864187 |
| 83 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.08864187 |
| 84 | replication fork processing (GO:0031297) | 3.08780062 |
| 85 | DNA damage induced protein phosphorylation (GO:0006975) | 3.06058860 |
| 86 | positive thymic T cell selection (GO:0045059) | 3.04839314 |
| 87 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.03359343 |
| 88 | regulation of hippo signaling (GO:0035330) | 3.02492062 |
| 89 | regulation of exit from mitosis (GO:0007096) | 2.99499502 |
| 90 | regulation of B cell differentiation (GO:0045577) | 2.99270117 |
| 91 | N-terminal protein amino acid acetylation (GO:0006474) | 2.98326305 |
| 92 | resolution of meiotic recombination intermediates (GO:0000712) | 2.96707073 |
| 93 | microtubule nucleation (GO:0007020) | 2.96060996 |
| 94 | formation of translation preinitiation complex (GO:0001731) | 2.94786437 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.93394626 |
| 96 | tolerance induction (GO:0002507) | 2.93102059 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.93066911 |
| 98 | negative regulation of DNA replication (GO:0008156) | 2.92627219 |
| 99 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.91976119 |
| 100 | female gonad development (GO:0008585) | 2.91189733 |
| 101 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.89648314 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89589914 |
| 103 | histone exchange (GO:0043486) | 2.89475797 |
| 104 | paraxial mesoderm development (GO:0048339) | 2.88942253 |
| 105 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88335221 |
| 106 | negative regulation of cell killing (GO:0031342) | 2.88335221 |
| 107 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.87928282 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 2.87862358 |
| 109 | regulation of double-strand break repair (GO:2000779) | 2.86903904 |
| 110 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.85687861 |
| 111 | thymic T cell selection (GO:0045061) | 2.84132624 |
| 112 | regulation of chromosome segregation (GO:0051983) | 2.83644671 |
| 113 | CENP-A containing nucleosome assembly (GO:0034080) | 2.83606616 |
| 114 | response to interleukin-15 (GO:0070672) | 2.81024876 |
| 115 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80906482 |
| 116 | DNA strand elongation (GO:0022616) | 2.79540389 |
| 117 | dosage compensation (GO:0007549) | 2.79057633 |
| 118 | leukocyte aggregation (GO:0070486) | 2.78366425 |
| 119 | spindle checkpoint (GO:0031577) | 2.78057537 |
| 120 | Peyers patch development (GO:0048541) | 2.76907960 |
| 121 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.76907960 |
| 122 | regulation of chromatin silencing (GO:0031935) | 2.75607514 |
| 123 | chromatin remodeling at centromere (GO:0031055) | 2.75048701 |
| 124 | T cell selection (GO:0045058) | 2.74831851 |
| 125 | histone H3-K9 methylation (GO:0051567) | 2.74705779 |
| 126 | chromatin assembly or disassembly (GO:0006333) | 2.73023920 |
| 127 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.72632621 |
| 128 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.72341756 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71692974 |
| 130 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.71187260 |
| 131 | histone H3-K4 methylation (GO:0051568) | 2.70865581 |
| 132 | reciprocal DNA recombination (GO:0035825) | 2.69710682 |
| 133 | reciprocal meiotic recombination (GO:0007131) | 2.69710682 |
| 134 | positive T cell selection (GO:0043368) | 2.69384885 |
| 135 | megakaryocyte development (GO:0035855) | 2.68346504 |
| 136 | nucleus organization (GO:0006997) | 2.67732059 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 2.67570973 |
| 138 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.67449983 |
| 139 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.66100874 |
| 140 | hepatocyte apoptotic process (GO:0097284) | 2.64513429 |
| 141 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.59845051 |
| 142 | DNA topological change (GO:0006265) | 2.59777642 |
| 143 | NIK/NF-kappaB signaling (GO:0038061) | 2.58101008 |
| 144 | cellular response to interleukin-4 (GO:0071353) | 2.57776220 |
| 145 | ribosomal small subunit biogenesis (GO:0042274) | 2.56856004 |
| 146 | regulation of granulocyte differentiation (GO:0030852) | 2.56544149 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.53665388 |
| 148 | positive regulation of isotype switching (GO:0045830) | 2.52805086 |
| 149 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51339931 |
| 150 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51339931 |
| 151 | modulation by symbiont of host immune response (GO:0052553) | 2.51339931 |
| 152 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51339931 |
| 153 | modulation by symbiont of host defense response (GO:0052031) | 2.51339931 |
| 154 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51339931 |
| 155 | erythrocyte development (GO:0048821) | 2.50559776 |
| 156 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49540133 |
| 157 | response to peptidoglycan (GO:0032494) | 2.49068731 |
| 158 | RNA stabilization (GO:0043489) | 2.47706656 |
| 159 | mRNA stabilization (GO:0048255) | 2.47706656 |
| 160 | cellular extravasation (GO:0045123) | 2.47354345 |
| 161 | telomere maintenance via recombination (GO:0000722) | 2.44491325 |
| 162 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.40368078 |
| 163 | regulation of histone H3-K27 methylation (GO:0061085) | 2.38528961 |
| 164 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.38371497 |
| 165 | cellular hyperosmotic response (GO:0071474) | 2.38236271 |
| 166 | IMP biosynthetic process (GO:0006188) | 2.37788670 |
| 167 | DNA replication initiation (GO:0006270) | 2.36360239 |
| 168 | necroptotic process (GO:0070266) | 2.34830367 |
| 169 | myeloid dendritic cell activation (GO:0001773) | 2.33483102 |
| 170 | V(D)J recombination (GO:0033151) | 2.33473760 |
| 171 | negative regulation of phagocytosis (GO:0050765) | 2.33256148 |
| 172 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.32579949 |
| 173 | viral mRNA export from host cell nucleus (GO:0046784) | 2.31714747 |
| 174 | programmed necrotic cell death (GO:0097300) | 2.31510500 |
| 175 | negative regulation of RNA splicing (GO:0033119) | 2.31170570 |
| 176 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.31118994 |
| 177 | natural killer cell differentiation (GO:0001779) | 2.31088006 |
| 178 | cellular response to interleukin-15 (GO:0071350) | 2.30235845 |
| 179 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.29981419 |
| 180 | ribosome biogenesis (GO:0042254) | 2.29366637 |
| 181 | negative regulation of necroptotic process (GO:0060546) | 2.26532284 |
| 182 | mitotic recombination (GO:0006312) | 2.26351399 |
| 183 | response to interleukin-4 (GO:0070670) | 2.25871144 |
| 184 | maturation of SSU-rRNA (GO:0030490) | 2.25664580 |
| 185 | response to protozoan (GO:0001562) | 2.25515521 |
| 186 | defense response to protozoan (GO:0042832) | 2.22804863 |
| 187 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.22601368 |
| 188 | DNA ligation (GO:0006266) | 2.21820812 |
| 189 | T cell homeostasis (GO:0043029) | 2.21701316 |
| 190 | negative regulation of mRNA processing (GO:0050686) | 2.21597520 |
| 191 | oxygen transport (GO:0015671) | 2.21439165 |
| 192 | detection of bacterium (GO:0016045) | 2.21143591 |
| 193 | IMP metabolic process (GO:0046040) | 2.20882646 |
| 194 | myeloid cell development (GO:0061515) | 2.20663283 |
| 195 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.20525199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.38382525 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 6.26844971 |
| 3 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.92778517 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.65860892 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.59172797 |
| 6 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.52982553 |
| 7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.31820928 |
| 8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.22230178 |
| 9 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.76678691 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.69093854 |
| 11 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.52710780 |
| 12 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.45206370 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.36100872 |
| 14 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.34541476 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.26073008 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19447577 |
| 17 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 2.11043706 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06343705 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04379978 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.00466802 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.98502090 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.95621274 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.92223298 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91693207 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.91067429 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86471190 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82622464 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74659333 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68961617 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66554439 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63020070 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60718307 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58088904 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56965231 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.56491669 |
| 36 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.55057092 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51306490 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.50543456 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49470529 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48602725 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48469619 |
| 42 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47825641 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46837042 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41853210 |
| 45 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40977185 |
| 46 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40425240 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40327026 |
| 48 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.39971593 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.39855777 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39696371 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39649590 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37752618 |
| 53 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.36762863 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36275996 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36090327 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.35552601 |
| 57 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.34265279 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33547361 |
| 59 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31811595 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27022684 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26674586 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.26642126 |
| 63 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.25614607 |
| 64 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23632631 |
| 65 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23301088 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21610984 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21444653 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21263938 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21098796 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19643886 |
| 71 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.19484922 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18753031 |
| 73 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17611656 |
| 74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16982893 |
| 75 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.15964760 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15761913 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15504276 |
| 78 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15147916 |
| 79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14764268 |
| 80 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14024739 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13804177 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13354657 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12763041 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12314270 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12076694 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12029804 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11124229 |
| 88 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10741795 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.09419154 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09177585 |
| 91 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09010683 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08983211 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08550064 |
| 94 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07261716 |
| 95 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07186664 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.06876212 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04830575 |
| 98 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04213873 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04094906 |
| 100 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.03907669 |
| 101 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.03887254 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02856622 |
| 103 | MYB_26560356_Chip-Seq_TH2_Human | 1.02427103 |
| 104 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01018946 |
| 105 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99890122 |
| 106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99364383 |
| 107 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95550596 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94747753 |
| 109 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94540298 |
| 110 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94020164 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93065707 |
| 112 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92963112 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91490591 |
| 114 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.91233009 |
| 115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89473058 |
| 116 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89394267 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89095584 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88708046 |
| 119 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88556317 |
| 120 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.87377099 |
| 121 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86055446 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85614500 |
| 123 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84977960 |
| 124 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.84200729 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84177798 |
| 126 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.84059058 |
| 127 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.83592626 |
| 128 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.83524416 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81948181 |
| 130 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81053490 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.79580685 |
| 132 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79265973 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 0.78186148 |
| 134 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75810121 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.73796373 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73267864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 4.37984514 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.24441906 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.54139687 |
| 4 | MP0003077_abnormal_cell_cycle | 3.42983118 |
| 5 | MP0008007_abnormal_cellular_replicative | 3.25499919 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.11392737 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.95615131 |
| 8 | MP0005451_abnormal_body_composition | 2.94220433 |
| 9 | MP0003436_decreased_susceptibility_to | 2.71512934 |
| 10 | MP0008058_abnormal_DNA_repair | 2.69738162 |
| 11 | MP0000685_abnormal_immune_system | 2.56101406 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.49189285 |
| 13 | MP0010307_abnormal_tumor_latency | 2.48859627 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.40235100 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.26692354 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.19714931 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.16411895 |
| 18 | MP0008260_abnormal_autophagy | 2.14897415 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.13614259 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.11894540 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 1.98738899 |
| 22 | MP0000350_abnormal_cell_proliferation | 1.98281655 |
| 23 | MP0000566_synostosis | 1.94051051 |
| 24 | MP0000490_abnormal_crypts_of | 1.91202454 |
| 25 | MP0001873_stomach_inflammation | 1.90942604 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.90916056 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.90916056 |
| 28 | MP0003787_abnormal_imprinting | 1.90594430 |
| 29 | MP0005025_abnormal_response_to | 1.87353923 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.78529992 |
| 31 | MP0002419_abnormal_innate_immunity | 1.76313259 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.72930075 |
| 33 | MP0001730_embryonic_growth_arrest | 1.69767157 |
| 34 | MP0009785_altered_susceptibility_to | 1.69507669 |
| 35 | MP0005408_hypopigmentation | 1.64069836 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.52368922 |
| 37 | MP0004947_skin_inflammation | 1.50784263 |
| 38 | MP0003724_increased_susceptibility_to | 1.47952465 |
| 39 | MP0005380_embryogenesis_phenotype | 1.46302773 |
| 40 | MP0001672_abnormal_embryogenesis/_devel | 1.46302773 |
| 41 | MP0008995_early_reproductive_senescence | 1.45779070 |
| 42 | MP0005310_abnormal_salivary_gland | 1.43992570 |
| 43 | MP0003890_abnormal_embryonic-extraembry | 1.39492093 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.38887538 |
| 45 | MP0003718_maternal_effect | 1.38793652 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.35652397 |
| 47 | MP0002163_abnormal_gland_morphology | 1.35122595 |
| 48 | MP0002102_abnormal_ear_morphology | 1.33024060 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.32129106 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.31616343 |
| 51 | MP0002398_abnormal_bone_marrow | 1.31464180 |
| 52 | MP0002210_abnormal_sex_determination | 1.29411448 |
| 53 | MP0003303_peritoneal_inflammation | 1.29024392 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.27095255 |
| 55 | MP0003984_embryonic_growth_retardation | 1.27004538 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.26678136 |
| 57 | MP0001853_heart_inflammation | 1.26318562 |
| 58 | MP0004147_increased_porphyrin_level | 1.25673978 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 1.24334961 |
| 60 | MP0003866_abnormal_defecation | 1.23794330 |
| 61 | MP0003937_abnormal_limbs/digits/tail_de | 1.22328933 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 1.22324215 |
| 63 | MP0001929_abnormal_gametogenesis | 1.22277674 |
| 64 | MP0002132_abnormal_respiratory_system | 1.20736668 |
| 65 | MP0002084_abnormal_developmental_patter | 1.20168881 |
| 66 | MP0002088_abnormal_embryonic_growth/wei | 1.19146291 |
| 67 | MP0002085_abnormal_embryonic_tissue | 1.18359306 |
| 68 | MP0001119_abnormal_female_reproductive | 1.17921628 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.17199797 |
| 70 | MP0000858_altered_metastatic_potential | 1.16883107 |
| 71 | MP0003786_premature_aging | 1.16752454 |
| 72 | MP0001697_abnormal_embryo_size | 1.15815912 |
| 73 | MP0009278_abnormal_bone_marrow | 1.11914476 |
| 74 | MP0001800_abnormal_humoral_immune | 1.09524540 |
| 75 | MP0001851_eye_inflammation | 1.08362280 |
| 76 | MP0005671_abnormal_response_to | 1.07325865 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 1.06935867 |
| 78 | MP0001835_abnormal_antigen_presentation | 1.06672545 |
| 79 | MP0000653_abnormal_sex_gland | 1.05873742 |
| 80 | MP0000689_abnormal_spleen_morphology | 1.04980517 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 1.04863191 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.03612079 |
| 83 | MP0008932_abnormal_embryonic_tissue | 1.03330336 |
| 84 | MP0002722_abnormal_immune_system | 1.02707048 |
| 85 | MP0000313_abnormal_cell_death | 1.02395267 |
| 86 | MP0001986_abnormal_taste_sensitivity | 1.01405830 |
| 87 | MP0001145_abnormal_male_reproductive | 1.00534031 |
| 88 | MP0008789_abnormal_olfactory_epithelium | 0.96426739 |
| 89 | MP0003172_abnormal_lysosome_physiology | 0.96047807 |
| 90 | MP0002006_tumorigenesis | 0.95974946 |
| 91 | MP0005647_abnormal_sex_gland | 0.94797509 |
| 92 | MP0000716_abnormal_immune_system | 0.94382835 |
| 93 | MP0002405_respiratory_system_inflammati | 0.93903286 |
| 94 | MP0002009_preneoplasia | 0.93530051 |
| 95 | MP0004381_abnormal_hair_follicle | 0.91741001 |
| 96 | MP0002080_prenatal_lethality | 0.91717372 |
| 97 | MP0008469_abnormal_protein_level | 0.91679006 |
| 98 | MP0003699_abnormal_female_reproductive | 0.91633767 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.89433718 |
| 100 | MP0000627_abnormal_mammary_gland | 0.88071542 |
| 101 | MP0003121_genomic_imprinting | 0.88014492 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.87594835 |
| 103 | MP0002452_abnormal_antigen_presenting | 0.86735919 |
| 104 | MP0005501_abnormal_skin_physiology | 0.86144451 |
| 105 | MP0001819_abnormal_immune_cell | 0.85869938 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.85221569 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.84783979 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.84678235 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.84667396 |
| 110 | MP0002429_abnormal_blood_cell | 0.84155790 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.84028552 |
| 112 | MP0009672_abnormal_birth_weight | 0.83723221 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.83574769 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.82805233 |
| 115 | MP0003123_paternal_imprinting | 0.82010213 |
| 116 | MP0005621_abnormal_cell_physiology | 0.81722196 |
| 117 | MP0005248_abnormal_Harderian_gland | 0.80998710 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80400672 |
| 119 | MP0003191_abnormal_cellular_cholesterol | 0.78249775 |
| 120 | MP0002723_abnormal_immune_serum | 0.76892839 |
| 121 | MP0000465_gastrointestinal_hemorrhage | 0.76665249 |
| 122 | MP0003806_abnormal_nucleotide_metabolis | 0.75331659 |
| 123 | MP0001663_abnormal_digestive_system | 0.74862296 |
| 124 | MP0001790_abnormal_immune_system | 0.73454459 |
| 125 | MP0005387_immune_system_phenotype | 0.73454459 |
| 126 | MP0000613_abnormal_salivary_gland | 0.72497799 |
| 127 | MP0000609_abnormal_liver_physiology | 0.71351054 |
| 128 | MP0009763_increased_sensitivity_to | 0.71001245 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.70835936 |
| 130 | MP0003186_abnormal_redox_activity | 0.70616635 |
| 131 | MP0003828_pulmonary_edema | 0.70139272 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.69907438 |
| 133 | MP0003935_abnormal_craniofacial_develop | 0.68982638 |
| 134 | MP0005083_abnormal_biliary_tract | 0.68065293 |
| 135 | MP0001915_intracranial_hemorrhage | 0.66372164 |
| 136 | MP0003315_abnormal_perineum_morphology | 0.65944216 |
| 137 | MP0003755_abnormal_palate_morphology | 0.62706755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 5.87336472 |
| 2 | Chromsome breakage (HP:0040012) | 5.61181552 |
| 3 | Prostate neoplasm (HP:0100787) | 5.37823059 |
| 4 | Facial hemangioma (HP:0000329) | 4.66429441 |
| 5 | Papillary thyroid carcinoma (HP:0002895) | 4.65948042 |
| 6 | Abnormality of the fingertips (HP:0001211) | 4.24206287 |
| 7 | Acute myeloid leukemia (HP:0004808) | 3.97767815 |
| 8 | Capillary hemangiomas (HP:0005306) | 3.92229657 |
| 9 | Abnormality of chromosome stability (HP:0003220) | 3.84695490 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 3.84516001 |
| 11 | Abnormality of the preputium (HP:0100587) | 3.83968932 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.68087166 |
| 13 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 3.62914356 |
| 14 | Meckel diverticulum (HP:0002245) | 3.55810504 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.54580441 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.52015699 |
| 17 | Abnormality of the prostate (HP:0008775) | 3.50584196 |
| 18 | Lip pit (HP:0100267) | 3.43370606 |
| 19 | Prolonged bleeding time (HP:0003010) | 3.38432408 |
| 20 | Abnormality of the ileum (HP:0001549) | 3.33522071 |
| 21 | Myelodysplasia (HP:0002863) | 3.32636335 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.28398802 |
| 23 | Ectopic kidney (HP:0000086) | 3.26305762 |
| 24 | Cholecystitis (HP:0001082) | 3.21862380 |
| 25 | Abnormal gallbladder physiology (HP:0012438) | 3.21862380 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.19449909 |
| 27 | Obstructive lung disease (HP:0006536) | 3.19449909 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 3.16966540 |
| 29 | Patellar aplasia (HP:0006443) | 3.07747390 |
| 30 | Abnormality of T cells (HP:0002843) | 3.07731994 |
| 31 | Petechiae (HP:0000967) | 3.04516087 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.04065352 |
| 33 | Meningitis (HP:0001287) | 3.00030567 |
| 34 | Clubbing of toes (HP:0100760) | 2.98202975 |
| 35 | Acute lymphatic leukemia (HP:0006721) | 2.95428225 |
| 36 | Stomatitis (HP:0010280) | 2.93113169 |
| 37 | Encephalitis (HP:0002383) | 2.89159114 |
| 38 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.85051693 |
| 39 | Thrombocytosis (HP:0001894) | 2.83333329 |
| 40 | T lymphocytopenia (HP:0005403) | 2.83198016 |
| 41 | Volvulus (HP:0002580) | 2.81054246 |
| 42 | Myositis (HP:0100614) | 2.79345164 |
| 43 | Abnormality of the carotid arteries (HP:0005344) | 2.79194165 |
| 44 | Thyroid carcinoma (HP:0002890) | 2.78155011 |
| 45 | Prominent nose (HP:0000448) | 2.77816441 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.77704441 |
| 47 | Hypertensive crisis (HP:0100735) | 2.77247455 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76432388 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.71598417 |
| 50 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.66736078 |
| 51 | Microcytic anemia (HP:0001935) | 2.66243369 |
| 52 | Small intestinal stenosis (HP:0012848) | 2.64759277 |
| 53 | Duodenal stenosis (HP:0100867) | 2.64759277 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.64318988 |
| 55 | Poikilocytosis (HP:0004447) | 2.62954016 |
| 56 | Epistaxis (HP:0000421) | 2.61349915 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.61240308 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.60680599 |
| 59 | Recurrent skin infections (HP:0001581) | 2.60679446 |
| 60 | Shawl scrotum (HP:0000049) | 2.59465040 |
| 61 | Abnormality of the labia minora (HP:0012880) | 2.55857775 |
| 62 | Abnormality of T cell number (HP:0011839) | 2.53418956 |
| 63 | Abnormality of male internal genitalia (HP:0000022) | 2.53205376 |
| 64 | Cellulitis (HP:0100658) | 2.51995143 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.51787934 |
| 66 | Long eyelashes (HP:0000527) | 2.50379574 |
| 67 | Vasculitis (HP:0002633) | 2.47805605 |
| 68 | Lymphopenia (HP:0001888) | 2.47118277 |
| 69 | Increased IgM level (HP:0003496) | 2.46981431 |
| 70 | Microvesicular hepatic steatosis (HP:0001414) | 2.45658476 |
| 71 | IgG deficiency (HP:0004315) | 2.45269369 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.43655218 |
| 73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42359581 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.42073664 |
| 75 | Granulocytopenia (HP:0001913) | 2.40579067 |
| 76 | Viral hepatitis (HP:0006562) | 2.40228707 |
| 77 | Lymphoma (HP:0002665) | 2.38324793 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.36088048 |
| 79 | Hypochromic anemia (HP:0001931) | 2.34583797 |
| 80 | Osteomyelitis (HP:0002754) | 2.34307091 |
| 81 | Progressive external ophthalmoplegia (HP:0000590) | 2.33771231 |
| 82 | Urticaria (HP:0001025) | 2.33634481 |
| 83 | Azoospermia (HP:0000027) | 2.33368078 |
| 84 | Pustule (HP:0200039) | 2.33245636 |
| 85 | Inflammation of the large intestine (HP:0002037) | 2.31593284 |
| 86 | Short thumb (HP:0009778) | 2.29426710 |
| 87 | IgA deficiency (HP:0002720) | 2.28772589 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.28565318 |
| 89 | Abnormal platelet volume (HP:0011876) | 2.28553309 |
| 90 | Spontaneous hematomas (HP:0007420) | 2.28440777 |
| 91 | Cholelithiasis (HP:0001081) | 2.24689997 |
| 92 | Bone marrow hypocellularity (HP:0005528) | 2.23203225 |
| 93 | Orchitis (HP:0100796) | 2.21058503 |
| 94 | Male infertility (HP:0003251) | 2.20897249 |
| 95 | Orthostatic hypotension (HP:0001278) | 2.20717983 |
| 96 | Overlapping toe (HP:0001845) | 2.19193846 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.19027128 |
| 98 | Retrobulbar optic neuritis (HP:0100654) | 2.18840848 |
| 99 | Optic neuritis (HP:0100653) | 2.18840848 |
| 100 | Pallor (HP:0000980) | 2.17904804 |
| 101 | Oligodactyly (HP:0012165) | 2.17829037 |
| 102 | Reticulocytosis (HP:0001923) | 2.15967576 |
| 103 | Entropion (HP:0000621) | 2.14683176 |
| 104 | Colitis (HP:0002583) | 2.13481175 |
| 105 | Chest pain (HP:0100749) | 2.12626898 |
| 106 | Abnormal spermatogenesis (HP:0008669) | 2.12469967 |
| 107 | Oligodactyly (hands) (HP:0001180) | 2.11134944 |
| 108 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.08583437 |
| 109 | Thoracolumbar scoliosis (HP:0002944) | 2.07937952 |
| 110 | Abnormal platelet function (HP:0011869) | 2.07754152 |
| 111 | Impaired platelet aggregation (HP:0003540) | 2.07754152 |
| 112 | Adrenal hypoplasia (HP:0000835) | 2.07510555 |
| 113 | Abnormality of the duodenum (HP:0002246) | 2.06871165 |
| 114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06467342 |
| 115 | Ragged-red muscle fibers (HP:0003200) | 2.06322192 |
| 116 | Flat capital femoral epiphysis (HP:0003370) | 2.06251894 |
| 117 | Seborrheic dermatitis (HP:0001051) | 2.05931343 |
| 118 | Impulsivity (HP:0100710) | 2.03900133 |
| 119 | Papilloma (HP:0012740) | 2.03763612 |
| 120 | Verrucae (HP:0200043) | 2.03763612 |
| 121 | Cafe-au-lait spot (HP:0000957) | 2.03558667 |
| 122 | Sparse lateral eyebrow (HP:0005338) | 2.01303064 |
| 123 | Abnormality of the thymus (HP:0000777) | 2.00540968 |
| 124 | Severe combined immunodeficiency (HP:0004430) | 1.99451745 |
| 125 | Abnormality of chromosome segregation (HP:0002916) | 1.97906125 |
| 126 | Acute hepatic failure (HP:0006554) | 1.97329203 |
| 127 | Abnormality of reticulocytes (HP:0004312) | 1.97304880 |
| 128 | Gingival bleeding (HP:0000225) | 1.97074918 |
| 129 | Abnormality of DNA repair (HP:0003254) | 1.95346455 |
| 130 | Breast aplasia (HP:0100783) | 1.95147117 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.94984343 |
| 132 | Increased mean platelet volume (HP:0011877) | 1.94376117 |
| 133 | Combined immunodeficiency (HP:0005387) | 1.93975727 |
| 134 | Urethral obstruction (HP:0000796) | 1.93299956 |
| 135 | Arteriovenous malformation (HP:0100026) | 1.92772108 |
| 136 | Abnormality of the columella (HP:0009929) | 1.92547079 |
| 137 | Amaurosis fugax (HP:0100576) | 1.92349193 |
| 138 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91521238 |
| 139 | Abnormality of the hepatic vasculature (HP:0006707) | 1.91238934 |
| 140 | Chronic diarrhea (HP:0002028) | 1.90178299 |
| 141 | Keratoconjunctivitis sicca (HP:0001097) | 1.89782925 |
| 142 | Abnormality of lateral ventricle (HP:0030047) | 1.87617623 |
| 143 | Microtia (HP:0008551) | 1.86527860 |
| 144 | Abnormal gallbladder morphology (HP:0012437) | 1.86281869 |
| 145 | Leukocytosis (HP:0001974) | 1.85889737 |
| 146 | Embryonal renal neoplasm (HP:0011794) | 1.85682793 |
| 147 | Anal stenosis (HP:0002025) | 1.85429278 |
| 148 | Breast hypoplasia (HP:0003187) | 1.85257973 |
| 149 | Tracheoesophageal fistula (HP:0002575) | 1.84162746 |
| 150 | Sloping forehead (HP:0000340) | 1.82702945 |
| 151 | Polycythemia (HP:0001901) | 1.82482794 |
| 152 | Ectropion (HP:0000656) | 1.78869835 |
| 153 | Squamous cell carcinoma (HP:0002860) | 1.78525234 |
| 154 | Recurrent viral infections (HP:0004429) | 1.77947465 |
| 155 | Triphalangeal thumb (HP:0001199) | 1.77269991 |
| 156 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.73586921 |
| 157 | Anal atresia (HP:0002023) | 1.73377588 |
| 158 | Ureteral obstruction (HP:0006000) | 1.72584639 |
| 159 | Hypoplasia of the fovea (HP:0007750) | 1.72172666 |
| 160 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72172666 |
| 161 | Microglossia (HP:0000171) | 1.71070759 |
| 162 | Poikiloderma (HP:0001029) | 1.69738088 |
| 163 | Arterial thrombosis (HP:0004420) | 1.68281659 |
| 164 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.68230899 |
| 165 | Ureteral stenosis (HP:0000071) | 1.67828237 |
| 166 | Thyroiditis (HP:0100646) | 1.66768744 |
| 167 | Blepharitis (HP:0000498) | 1.66111468 |
| 168 | Coarctation of aorta (HP:0001680) | 1.65288529 |
| 169 | Hypoplastic iliac wings (HP:0002866) | 1.64155594 |
| 170 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.63836090 |
| 171 | Fatigue (HP:0012378) | 1.62552590 |
| 172 | IgM deficiency (HP:0002850) | 1.62461827 |
| 173 | Recurrent fungal infections (HP:0002841) | 1.62276759 |
| 174 | Heterotopia (HP:0002282) | 1.61580667 |
| 175 | Recurrent cutaneous fungal infections (HP:0011370) | 1.59920067 |
| 176 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.59920067 |
| 177 | Spontaneous abortion (HP:0005268) | 1.59414960 |
| 178 | Agammaglobulinemia (HP:0004432) | 1.57533103 |
| 179 | Leukopenia (HP:0001882) | 1.57251867 |
| 180 | Abnormality of the line of Schwalbe (HP:0008048) | 1.57143188 |
| 181 | Horseshoe kidney (HP:0000085) | 1.56934191 |
| 182 | Truncal obesity (HP:0001956) | 1.55457705 |
| 183 | Carpal bone hypoplasia (HP:0001498) | 1.54440790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 7.85689557 |
| 2 | STK38L | 5.69131027 |
| 3 | LATS2 | 5.46576189 |
| 4 | CDC7 | 3.32168103 |
| 5 | STK3 | 3.05633285 |
| 6 | PRPF4B | 3.01824455 |
| 7 | SMG1 | 2.71471594 |
| 8 | RIPK4 | 2.66847230 |
| 9 | CDK12 | 2.66609744 |
| 10 | NEK2 | 2.16676927 |
| 11 | SRPK1 | 2.08272302 |
| 12 | MAP3K14 | 2.05467890 |
| 13 | MAP3K13 | 2.04116521 |
| 14 | GRK6 | 1.94273381 |
| 15 | TAOK3 | 1.93479485 |
| 16 | TAOK2 | 1.89548591 |
| 17 | MAP3K10 | 1.77959118 |
| 18 | NME2 | 1.64301328 |
| 19 | PLK4 | 1.63164110 |
| 20 | STK38 | 1.60880170 |
| 21 | CHEK2 | 1.55886129 |
| 22 | JAK3 | 1.54323819 |
| 23 | ERN1 | 1.54165954 |
| 24 | VRK2 | 1.50693320 |
| 25 | BTK | 1.47551538 |
| 26 | TTK | 1.44706230 |
| 27 | TAOK1 | 1.42277096 |
| 28 | ABL2 | 1.39125546 |
| 29 | BRSK2 | 1.33030859 |
| 30 | SYK | 1.30291772 |
| 31 | DYRK3 | 1.29887734 |
| 32 | EEF2K | 1.29778468 |
| 33 | MAP4K1 | 1.29633297 |
| 34 | FRK | 1.27274662 |
| 35 | MKNK2 | 1.26324957 |
| 36 | MAP3K6 | 1.25929688 |
| 37 | CDK8 | 1.25738818 |
| 38 | BLK | 1.23535000 |
| 39 | IKBKE | 1.22187570 |
| 40 | PLK1 | 1.20716813 |
| 41 | CSK | 1.19909958 |
| 42 | PASK | 1.19671382 |
| 43 | TESK2 | 1.17949783 |
| 44 | FES | 1.16024443 |
| 45 | AURKB | 1.13277715 |
| 46 | WEE1 | 1.12565009 |
| 47 | CHEK1 | 1.11312248 |
| 48 | ERBB4 | 1.11005083 |
| 49 | CAMK1D | 1.10991452 |
| 50 | MAP3K11 | 1.08480077 |
| 51 | MST4 | 1.06259861 |
| 52 | STK24 | 1.01867628 |
| 53 | PDGFRB | 1.00933379 |
| 54 | SIK3 | 1.00536188 |
| 55 | CDK4 | 1.00384949 |
| 56 | BUB1 | 0.98000344 |
| 57 | CDK9 | 0.97800633 |
| 58 | NUAK1 | 0.97257403 |
| 59 | FGR | 0.97167777 |
| 60 | ATM | 0.97122858 |
| 61 | TBK1 | 0.96780153 |
| 62 | CDK7 | 0.96759787 |
| 63 | ITK | 0.96344304 |
| 64 | IRAK3 | 0.89919380 |
| 65 | PIM1 | 0.89346718 |
| 66 | LYN | 0.88279729 |
| 67 | MAP3K1 | 0.87930139 |
| 68 | LRRK2 | 0.87465368 |
| 69 | VRK1 | 0.87065143 |
| 70 | TRIB3 | 0.85106248 |
| 71 | ATR | 0.84839532 |
| 72 | MELK | 0.83526272 |
| 73 | STK4 | 0.83046257 |
| 74 | SCYL2 | 0.82902646 |
| 75 | STK10 | 0.82477982 |
| 76 | FGFR4 | 0.81299931 |
| 77 | KDR | 0.81087184 |
| 78 | CDK3 | 0.80461928 |
| 79 | MATK | 0.80294552 |
| 80 | CSF1R | 0.78956785 |
| 81 | RAF1 | 0.77849392 |
| 82 | RPS6KB2 | 0.76677100 |
| 83 | ABL1 | 0.76562198 |
| 84 | PLK3 | 0.75981633 |
| 85 | BRD4 | 0.75303021 |
| 86 | ZAK | 0.73534375 |
| 87 | ICK | 0.73472622 |
| 88 | LCK | 0.71316040 |
| 89 | ACVR1B | 0.67268766 |
| 90 | EIF2AK3 | 0.66586631 |
| 91 | TAF1 | 0.65748579 |
| 92 | CCNB1 | 0.65238788 |
| 93 | ARAF | 0.62769535 |
| 94 | BRSK1 | 0.61211155 |
| 95 | HIPK2 | 0.60458636 |
| 96 | TEC | 0.59792719 |
| 97 | CDK2 | 0.59612685 |
| 98 | MAP3K3 | 0.59136579 |
| 99 | CHUK | 0.58373113 |
| 100 | CAMK1G | 0.57567099 |
| 101 | STK16 | 0.56945583 |
| 102 | MARK3 | 0.56775413 |
| 103 | PRKD2 | 0.55368473 |
| 104 | TNK2 | 0.54976587 |
| 105 | IRAK4 | 0.54684412 |
| 106 | JAK1 | 0.54423936 |
| 107 | BRAF | 0.54359841 |
| 108 | MKNK1 | 0.52930719 |
| 109 | PRKAA1 | 0.52234353 |
| 110 | PRKAA2 | 0.51153454 |
| 111 | BMPR2 | 0.51125434 |
| 112 | MAPKAPK2 | 0.51029981 |
| 113 | MAP3K5 | 0.50515722 |
| 114 | SIK1 | 0.49678214 |
| 115 | MAP2K2 | 0.49250342 |
| 116 | CDK19 | 0.48421430 |
| 117 | YES1 | 0.47975158 |
| 118 | IRAK2 | 0.47460723 |
| 119 | MAPK10 | 0.46341903 |
| 120 | MOS | 0.46223077 |
| 121 | CDK1 | 0.46216768 |
| 122 | IRAK1 | 0.43973671 |
| 123 | TXK | 0.43036610 |
| 124 | DAPK1 | 0.42516260 |
| 125 | CDK6 | 0.41973549 |
| 126 | IKBKB | 0.41831992 |
| 127 | MAP3K8 | 0.41738330 |
| 128 | DYRK2 | 0.41301934 |
| 129 | DMPK | 0.40280557 |
| 130 | EPHA3 | 0.40269219 |
| 131 | EIF2AK2 | 0.40171602 |
| 132 | ALK | 0.39692763 |
| 133 | EIF2AK1 | 0.39090297 |
| 134 | HCK | 0.37080916 |
| 135 | RPS6KA4 | 0.35064448 |
| 136 | FGFR3 | 0.34761608 |
| 137 | MAPK14 | 0.33382676 |
| 138 | JAK2 | 0.31828154 |
| 139 | MAPK11 | 0.31116449 |
| 140 | TRPM7 | 0.30846774 |
| 141 | MAP2K3 | 0.29972282 |
| 142 | AKT1 | 0.27555913 |
| 143 | SGK2 | 0.27531614 |
| 144 | MUSK | 0.26638927 |
| 145 | CLK1 | 0.26015281 |
| 146 | TYK2 | 0.25887727 |
| 147 | KIT | 0.24941462 |
| 148 | CSNK1D | 0.24818395 |
| 149 | PRKD3 | 0.24083209 |
| 150 | NLK | 0.23316944 |
| 151 | ZAP70 | 0.20923792 |
| 152 | GSK3B | 0.18996815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cell cycle_Homo sapiens_hsa04110 | 3.33982923 |
| 2 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 3.13214055 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.02755501 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 2.79983763 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.63773626 |
| 6 | Basal transcription factors_Homo sapiens_hsa03022 | 2.57724559 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.28687968 |
| 8 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.25317788 |
| 9 | RNA degradation_Homo sapiens_hsa03018 | 2.21908894 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.02444982 |
| 11 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.91359729 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.78444486 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.75499853 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73013912 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.69962630 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.62161526 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.59462608 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59145766 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.58668761 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51236756 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.50655146 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50257789 |
| 23 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.50185071 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.41464275 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37731272 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34868696 |
| 27 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34086813 |
| 28 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.30463091 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.30283786 |
| 30 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.26701400 |
| 31 | Base excision repair_Homo sapiens_hsa03410 | 1.25298705 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.24485308 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.22788113 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22101422 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20681029 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.19551282 |
| 37 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.18737691 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.16101182 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14523623 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13324436 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.13047628 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09801347 |
| 43 | Thyroid cancer_Homo sapiens_hsa05216 | 1.09048185 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.08580137 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06590279 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05407721 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03999252 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 1.03286692 |
| 49 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02487897 |
| 50 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.01977531 |
| 51 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.01258026 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01018676 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00891911 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00508142 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98395603 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 0.97181216 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96025510 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95168653 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92588195 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.87104291 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85959143 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85709960 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84106219 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83938601 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83122008 |
| 66 | Malaria_Homo sapiens_hsa05144 | 0.82870981 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.81463416 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79767303 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79292389 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78879379 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78023357 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74003715 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71837973 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.71812283 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67651417 |
| 76 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67224850 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67021854 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66497056 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.66213744 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65826467 |
| 81 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65814424 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65578985 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.64861975 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63921259 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63250645 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61657395 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61470778 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61123716 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60654289 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59534704 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59509027 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59202211 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.59184283 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58107664 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56553233 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53903495 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52934401 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.52731093 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52642687 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52308341 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52132371 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52074825 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51335144 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50295549 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50128663 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.49280030 |
| 107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.48707156 |
| 108 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.48673429 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48556068 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47696984 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47368091 |
| 112 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47184030 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.45836460 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.43231840 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41793445 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41640574 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39004413 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37374685 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36522749 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.34854788 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34393206 |
| 122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34305885 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34251231 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33947863 |
| 125 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32236237 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31384380 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30330297 |

